Identification of synergistic drug combinations for therapy of IDH-mutated glioma

Authors :: Stammler, F
Warta, R
Herold-Mende, C
Unterberg, AW
Source :: 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie; 20220529-20220601; Köln; DOCV134 /20220525/
Publication Year :: 2022
Publisher :: German Medical Science GMS Publishing House, 2022.
Abstract: Objective: Isocitrate Dehydrogenase-mutated (IDHmut) and wildtype (IDHwt) gliomas are regarded as separate tumor entities with the need for accordingly adjusted therapies. IDHmut tumors have a better prognosis than the wildtype. Nevertheless they are still not curable since there is no effective drug [for full text, please go to the a.m. URL]

Language :: English
Database :: OpenAIRE
Journal :: 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie; 20220529-20220601; Köln; DOCV134 /20220525/
Accession number :: edsair.doi.dedup.....e1e7297afb53e53fb34f92d248ffb9fd
Full Text :: https://doi.org/10.3205/22dgnc134

Full Text Access

Tools